Stifel maintains Buy on Denali Therapeutics, $37 target
Stifel analysts confirmed their Buy rating on Denali Therapeutics Inc. (NASDAQ:DNLI) with a steady price target of $37.00. According to InvestingPro data, analysts maintain a Strong Buy consensus with ...
Wells Fargo cuts Church & Dwight price target to $165
Wells Fargo (NYSE:WFC) analyst Chris Carey adjusted the price target for Church & Dwight Co. Inc. (NYSE:CHD) stock to $165 from the previous $168 while maintaining an Overweight rating. The revision ...